| Name | Enobosarm |
|---|---|
| Synonyms |
OSTINE;MK-2866;GTX-024;MK2866;GTX024;MK 2866;GTX 024;ENOBOSM
EnobosM MK-2286 Ostine NOT FOR SALE-PATENTED (S)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropionamide (2S)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide Purity OSTINE(MK-2866) (S)-3-(4-Cyanophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide Ostine (GTx-024,MK-2866) PropanaMide, 3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoroMethyl)phenyl]-2-hydroxy-2-Methyl-, (2S) Ostine/MK-2866 25mg Tablets OSTINE(MK-2866) Purity (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide MK2866(S-22) Ostine, >= Qstine,MK-2866,(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide OSTINE 841-8 MK-2866 Enobosm MK-2866 (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide //BP MK 2866 MK-2886 MK2866(GTx-024,Ostine) Mk 2866 Ostine Sms Powder Mk2866 Ostine,GTx-024 Ostine MK677,MK2866 /1202-9 Phmaceutical Raw Materials Ostine MK-2866 Enobosm Ostine MK-286 (S)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide MK-2866, Ostine ENOBOSAM(MK2866) (Ostine) GTx-024 OSTINE(MK-2866) Phmaceutical ade Qstine/MK-2866 ENOBOSAM(MK2866) UNII-O3571H3R8N High Quality OSTINE(MK-2866) Ostine, 10 mM in DMSO enobosm (ostine ) OSTINE(MK-2866) with High quality MK-2866 (GTx-024) OSTINE;MK-2866;GTX-024;MK2866;GTX024;MK 2866;GTX 024 Ostine(MK2286) |
| Description | Ostarine(MK-2866; GTX-024) is a modulator of human androgen receptor.IC50 value:Target: androgen receptorOstarine (MK-2866) is an androgen receptor modulator (SARM) with an ED50 of 0.44 mg/day. Ostarine (MK-2866) has anabolic activity. Lack of PSA increases in men and hair growth in women further corroborated selective anabolic effects of Ostarine (MK-2866). Ostarine (MK-2866) also resulted in a dose-dependent decrease in LDL and HDL cholesterol levels, with the average LDL/HDL ratio for all doses remaining in the low cardiovascular risk catergory. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 632.3±55.0 °C at 760 mmHg |
| Molecular Formula | C19H14F3N3O3 |
| Molecular Weight | 389.328 |
| Flash Point | 336.2±31.5 °C |
| Exact Mass | 389.098724 |
| PSA | 106.14000 |
| LogP | 4.83 |
| Vapour Pressure | 0.0±2.0 mmHg at 25°C |
| Index of Refraction | 1.578 |